Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-159,991
Closed -$12.1M 1187
2026
Q1
$12.1M Buy
159,991
+5,000
+3% +$376K 0.03% 397
2025
Q4
$11.5M Sell
154,991
-14,446
-9% -$1.06M 0.03% 418
2025
Q3
$11.4M Buy
169,437
+20,950
+14% +$1.39M 0.03% 398
2025
Q2
$9.68M Sell
148,487
-1,896
-1% -$114K 0.02% 432
2025
Q1
$9.29M Buy
150,383
+15,001
+11% +$994K 0.03% 419
2024
Q4
$9.76M Buy
135,382
+20,200
+18% +$1.58M 0.03% 410
2024
Q3
$9.38M Sell
115,182
-113,656
-50% -$9.09M 0.03% 403
2024
Q2
$17M Buy
228,838
+19,048
+9% +$1.43M 0.06% 260
2024
Q1
$16.4M Buy
+209,790
New +$15.6M 0.05% 322

Other funds holding HOLX

Danske Bank's HOLX Position: Q2 2026 in Review

Danske Bank sold out of Hologic (HOLX) in Q2 2026, closing a stake of 159,991 shares — an estimated $12.1M sold.

Danske Bank first reported a position in HOLX in Q1 2024 and held it in 9 quarters. The position peaked at $17M in Q2 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Danske Bank reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Danske Bank sold 159,991 Hologic shares in Q2 2026, an estimated $12.1M.
  • Danske Bank first reported a position in Hologic in Q1 2024 and held it in 9 quarters.
  • Danske Bank's Hologic position peaked at $17M in Q2 2024.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.